“In Vivo Inhibitory Effect of Suberoylanilide Hydroxamic Acid Combined With Sorafenib on Human Hepatocellular Carcinoma Cells”. 2020. Brazilian Journal of Pharmaceutical Sciences 56 (December): e18254. https://doi.org/10.1590/s2175-97902019000318254.